Fox Chase Cancer Center at Temple University Hospital has earned re-accreditation from the National Accreditation Program for Breast Centers (NAPBC) at the American College of Surgeons (ACS).
To earn a three-year renewal of this prestigious accreditation, the ACS required Fox Chase Cancer Center at Temple University Hospital’s breast cancer program to meet rigorous NAPBC standards for clinical services, research, community outreach, professional education, and quality improvement for patients.
Fox Chase Cancer Center at Temple University Hospital received zero deficiencies in its June site visit from the ACS — recognition that Temple Health is meeting the highest standards of continued quality care and improvement in its breast cancer program, said Richard J. Bleicher, MD, FACS, chief of the Division of Breast Surgery and Temple Health's clinical director of the breast service line.
“Earning NAPBC re-accreditation demonstrates the commitment of our clinicians and surgeons to providing high-quality, multidisciplinary treatment and promoting ongoing evidence-based care in our breast cancer program,” Bleicher said. "We are proud of our breast cancer program's legacy of enhancing patient outcomes by providing state-of-the-art care, as well as care for the individual. That is a byproduct of the combined expertise and resources of Temple University Hospital and Fox Chase Cancer Center — two of Philadelphia’s most respected healthcare providers."
"An unwavering focus on improving patient outcomes"
A re-accreditation report from NAPBC's surveyors called attention to the clinical excellence of Fox Chase Cancer Center at Temple University Hospital, coupled with its profound impact on the Philadelphia community.
The report highlighted Temple University Hospital's commitments to ensuring equitable access to high-quality breast cancer services, providing care for a diverse and medically underserved population, and supporting patients across the continuum of care — including genetic counseling, survivorship planning, and multidisciplinary treatment planning.
Clinical research participation rates at Fox Chase Cancer Center at Temple University Hospital "substantially exceed accreditation requirements," the report stated, "bringing advanced treatment options and innovative therapies to patients throughout the region."
With specialized personnel, advanced technology, and process-improvement initiatives aimed at strengthening care delivery, Fox Chase Cancer Center at Temple University Hospital has "an unwavering focus on improving outcomes for patients," the report said.
"At Fox Chase Cancer Center at Temple University Hospital, we believe every patient deserves access to exceptional cancer care, regardless of the challenges they may face," said Roxana Taveira, associate vice president of oncology services at Temple Health. "This re-accreditation recognizes the dedication of our teams to not only provide the highest quality breast cancer care, but also to remove barriers, support patients throughout their journey, and improve outcomes for the communities we are privileged to serve."
An accreditation standard
NAPBC accreditation for Fox Chase Cancer Center at Temple University Hospital complements the nearly two-decade history of Fox Chase Cancer Center’s accreditation by NAPBC.